105 related articles for article (PubMed ID: 26563368)
1. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma.
Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W
Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte-elevated gene-1 mediates insulin-like growth factor 1-induced the progression of cardiac myxoma.
Fang C; Shen Y; Qi P; Liu Z; Zhang M; Pang X
Tumour Biol; 2015 Dec; 36(12):9769-77. PubMed ID: 26156800
[TBL] [Abstract][Full Text] [Related]
3. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D.
Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y
Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649
[TBL] [Abstract][Full Text] [Related]
4. PPARγ suppresses the proliferation of cardiac myxoma cells through downregulation of MEF2D in a miR-122-dependent manner.
Qiu Y; Yang J; Bian S; Chen G; Yu J
Biochem Biophys Res Commun; 2016 Jun; 474(3):560-565. PubMed ID: 27109478
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I suppresses degradation of the pro-survival transcription factor myocyte enhancer factor 2D (MEF2D) during neuronal apoptosis.
Butts BD; Linseman DA; Le SS; Laessig TA; Heidenreich KA
Horm Metab Res; 2003; 35(11-12):763-70. PubMed ID: 14710356
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte elevated gene-1 regulates CCL3/CCR5-induced epithelial-to-mesenchymal transition via Erk1/2 and Akt signaling in cardiac myxoma.
Shi P; Fang C; Pang X
Oncol Rep; 2015 Sep; 34(3):1319-26. PubMed ID: 26134542
[TBL] [Abstract][Full Text] [Related]
7. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.
Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J
Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765
[TBL] [Abstract][Full Text] [Related]
8. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
Xu K; Zhao YC
Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
[TBL] [Abstract][Full Text] [Related]
9. miR-217 suppresses proliferation and promotes apoptosis in cardiac myxoma by targeting Interleukin-6.
Zhang J; Wang C; Xu H
Biochem Biophys Res Commun; 2017 Aug; 490(3):713-718. PubMed ID: 28642131
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death.
Yang S; Gao L; Lu F; Wang B; Gao F; Zhu G; Cai Z; Lai J; Yang Q
J Neuroinflammation; 2015 Feb; 12():33. PubMed ID: 25890150
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of atorvastatin on the cell growth of cardiac myxomas via the PTEN and PHLPP2 phosphatase signaling pathway.
Wu XL; Yang DY; Tan DJ; Yao HC; Chai W; Peng L
Oncol Rep; 2013 Aug; 30(2):757-62. PubMed ID: 23715723
[TBL] [Abstract][Full Text] [Related]
12. miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression.
Song L; Li D; Zhao Y; Gu Y; Zhao D; Li X; Bai X; Sun Y; Zhang X; Sun H; Wang Y; Peng L
Tumour Biol; 2016 Mar; 37(3):2891-900. PubMed ID: 26409449
[TBL] [Abstract][Full Text] [Related]
13. Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer.
Zhu HX; Shi L; Zhang Y; Zhu YC; Bai CX; Wang XD; Zhou JB
J Transl Med; 2017 Mar; 15(1):65. PubMed ID: 28340574
[TBL] [Abstract][Full Text] [Related]
14. MEF2D Functions as a Tumor Suppressor in Breast Cancer.
Wang X; Shen H; Chen Y; Zhang Y; Wang J; Liu S; Xu B; Wang H; Frangou C; Zhang J
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791246
[TBL] [Abstract][Full Text] [Related]
15. Myocyte enhancer factor 2D regulates ectoderm specification and adhesion properties of animal cap cells in the early Xenopus embryo.
Katz Imberman S; Kolpakova A; Keren A; Bengal E
FEBS J; 2015 Aug; 282(15):2930-47. PubMed ID: 26038288
[TBL] [Abstract][Full Text] [Related]
16. MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
Zhang Y; Lin W; Yang Y; Zhu S; Chen Y; Wang H; Teng L
Cancer Lett; 2024 Jun; 591():216878. PubMed ID: 38609001
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
[TBL] [Abstract][Full Text] [Related]
18. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyogenic differentiation in cardiac myxoma expressing lineage-specific transcription factors.
Kodama H; Hirotani T; Suzuki Y; Ogawa S; Yamazaki K
Am J Pathol; 2002 Aug; 161(2):381-9. PubMed ID: 12163362
[TBL] [Abstract][Full Text] [Related]
20. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
